10x Genomics, Inc. · NASDAQ:TXG
Teichmann Sarah A. sold 7,551 10x Genomics, Inc. shares (Form 4)
Traded Aug 13 to Aug 14, 2026 · Filed Aug 17, 2026
From Aug 13 to Aug 14, 2026, Teichmann Sarah A. (Director) sold 7,551 10x Genomics, Inc. shares at an average US$57.25 for US$432K under a trading plan, leaving 28,058 shares. Filed Aug 17, 2026 (Form 4).
- Sold
- 7,551 shares
- Price
- US$57.25 average (US$57.15 to US$57.29)
- Value
- US$432K
- Holding after
- 28,058 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Class A Common Stock | Sale | 5,278 | US$57.29 | 30,331 | Direct |
| Aug 14, 2026 | Class A Common Stock | Sale | 2,273 | US$57.15 | 28,058 | Direct |
Source
Related
- 10x Genomics, Inc.
- Teichmann Sarah A.
- 10x Genomics, Inc. shareholders
- Form 4 · Teichmann Sarah A. · Jun 8, 2026
- Schedule 13G/A · ARK Investment Management LLC · Oct 7, 2026
- Form 4 · Suliman Shehnaaz · Sep 24, 2026
- Form 4 · Saxonov Serge · Sep 24, 2026
- Form 4 · Taich Adam · Sep 11, 2026
- Form 4 · Stuelpnagel John R · Sep 8, 2026